IRVINE, CA , Jan. 31, 2018 (GLOBE NEWSWIRE) — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that the Company’s research team is expanding the scope of its current cancer research to include Leukemia. Read More
The post Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing … appeared first on Dagga Magazine.